How This Actually Works, Step by Step

You are not booking a hotel room. You are entering a medical system that runs on documentation, in-person evaluations, and sequential approvals. Here is the sequence we guide patients through every week.

First, you send your existing medical records — biopsy reports, imaging files, current medication list, and a brief history in English. Our team translates these into Chinese and routes them to the appropriate department at a hospital that matches your condition. A specialist reviews the file and tells us whether they can take your case and what additional tests they would need.

If the answer is yes, the next step is usually a video consultation. You speak directly with the Chinese medical team. They explain their proposed protocol, expected timeline, and whether your case fits their current capacity. This step costs between $100 and $800 depending on whether you are seeing a general international department physician or a top specialist. That fee is credited in full toward on-the-ground coordination if you proceed within 90 days.

Only after the medical team confirms feasibility do we move to logistics: S2 visa application, accommodation near the hospital, and an arrival plan. You cannot lock in a surgery date from overseas. You must first arrive, complete the in-person outpatient visit, and then the hospital schedules admission based on bed availability and clinical priority.

And here is what surprises most people: the actual medical treatment is often the most predictable part. The unpredictable parts are document translation lead times, visa processing windows, and the sheer physical exhaustion of navigating a massive hospital campus in a language you don’t read.

Long-Term Cancer Care in China: What the Numbers Actually Look Like

Let’s talk about the primary concern: the long term cancer treatment cost China hospitals charge compared to what you would pay at home. The honest answer is that it varies enormously by cancer type, stage, drug regimen, and hospital tier. But the structural gap is real.

Chemotherapy cycles at a top public hospital in Beijing or Shanghai typically run $3,000 to $8,000 per cycle for standard regimens. Immunotherapy drugs add $5,000 to $15,000 per cycle depending on the specific agent. Radiation therapy courses land between $8,000 and $25,000 for a full course. Compare that to the United States, where a single immunotherapy infusion can exceed $20,000 before insurance and a full radiation course routinely passes $60,000.

Those numbers sound attractive. But they come with conditions.

Public hospital international departments charge 1.5 to 2 times the standard rate for the same treatment because you get English-speaking coordination, shorter wait times for consultations, and help with the administrative maze. That premium is not a bribe. It is the cost of the infrastructure that makes your treatment logistically possible as a foreigner.

Private international hospitals like United Family or Jiahui charge more still — often comparable to mid-tier Western private care — but they offer direct insurance billing and a fully Western-style experience. For a six-month oncology protocol at a private international hospital, you should budget $60,000 to $150,000 depending on drug choices. At a public hospital international department, the same protocol might run $35,000 to $80,000.

The decision is not simply “cheaper is better.” A patient who needs frequent dose adjustments and close monitoring may find the private hospital’s responsiveness worth the premium. A patient with a stable, standard protocol may do perfectly well at a public hospital’s international wing.

A Realistic Timeline

People consistently underestimate the pre-treatment runway. Here is what a typical long-term oncology patient actually experiences.

The waiting steps people forget are the document translation and the specialist’s review queue. A top oncologist at Peking Union Medical College Hospital or Fudan University Shanghai Cancer Center is reviewing dozens of international files every week. Your case gets a slot, but it is not instant.

Visa processing is another silent delay. The S2 visa for medical treatment typically allows stays of up to 180 days. If your protocol runs longer, you apply for an S1 visa or extend your S2 while in China. Extensions require updated hospital documentation confirming ongoing treatment necessity. Budget two to four weeks for any visa-related administrative step.

What Can Go Wrong — and What Happens Then

We would rather tell you now than have you discover it at the hospital registration desk.

The most common failure is the specialist declining your case after remote review. This happens when the disease has progressed beyond what the Chinese protocol can meaningfully address, or when the hospital’s current patient load cannot absorb a complex international case. If that happens, we route your file to a second or third hospital. You are not obligated to proceed with the first institution that reviews your records.

The second failure mode is insurance rejection. Many international insurers require pre-authorization for treatment in China, and some exclude certain public hospital international departments. You need written confirmation from your insurer before you fly. If coverage is denied, you can still proceed as a self-pay patient, but the budget changes dramatically.

The third is clinical mismatch. A patient arrives expecting a specific drug regimen, but the Chinese oncologist recommends a different protocol based on local clinical guidelines and drug availability. Some newer immunotherapies approved in the US or Europe are not yet approved in China, or are approved under different indications. You may need a written second opinion from your home oncologist to reconcile the difference.

And sometimes, the patient simply finds the experience too exhausting. A 10,000-patient-per-day hospital campus, even with a bilingual companion, is intense. We have seen patients decide after two weeks that they would rather return home and continue treatment there. That is a legitimate choice. You are never locked in.

Evaluating a Hospital for Chronic Disease Management

Acute care is China’s strength — high surgical volumes, rapid diagnostics, aggressive intervention. But chronic disease management requires something different: continuity, communication, and a team that sees you as a long-term patient rather than a single procedure.

So how do you evaluate a hospital for that purpose? Start with its department structure. Does the hospital have a dedicated chronic disease center, or is everything routed through general outpatient clinics? Top institutions like Fudan-ranked public hospitals increasingly operate integrated centers for oncology, cardiovascular disease, and metabolic disorders where the same team follows you across months of treatment.

Ask about the follow-up mechanism. Will you see the same specialist at each visit, or a rotating roster of junior doctors? In public hospitals, continuity often depends on the specific department’s internal organization. Private international hospitals generally offer better continuity but at a higher price point.

Check what rehabilitation infrastructure exists. This matters enormously for stroke recovery, post-surgical orthopedic cases, and cancer patients managing treatment side effects. Some Shanghai hospitals run dedicated rehabilitation wards with physiotherapy, occupational therapy, and TCM adjuncts like acupuncture. Others discharge you to outpatient rehab with minimal coordination.

And confirm the hospital’s experience with international long-stay patients specifically. A hospital that performs 5,000 cardiac surgeries a year may have almost no experience managing a foreign patient’s six-month follow-up schedule, insurance paperwork, and visa documentation. That administrative gap can derail an otherwise excellent clinical plan.

Practical Considerations: Visas, Payment, and Follow-Up at Home

The medical visa for extended treatment China issues is one of the most misunderstood parts of this process. The S2 visa is the correct category for medical treatment and private affairs, typically issued for stays up to 180 days. Family members accompanying you also apply for S2. For treatment extending beyond six months, the S1 visa applies, or you extend your S2 from within China with hospital documentation. The M visa is for commercial and trade activities and has nothing to do with medical travel.

Embassy requirements shift. Always check the latest requirements for your nationality before applying. You will need a hospital invitation letter, proof of financial means, and sometimes a detailed treatment plan. We help prepare these documents, but we cannot guarantee approval. No one can.

Payment works differently than you may expect. Public hospitals require prepayment — you deposit funds at admission and the hospital draws down as services are delivered. Insurance reimbursement is almost always retrospective: you pay first, submit claims, and wait for your insurer to process. Private international hospitals with direct billing agreements are the exception.

Language is not a minor inconvenience. It is the difference between understanding your medication schedule and guessing. A bilingual medical companion handles registration, queueing, payment, translation during consultations, and post-visit instructions. This runs from $300 per day. For a six-month treatment protocol with twice-weekly hospital visits, that is a significant line item. Budget for it.

Follow-up at home needs planning before you leave China. Your Chinese oncologist should provide a written summary in English, including exact drug names, dosages, and recommended monitoring intervals. Your home physician needs that document to continue care safely. Some patients arrange periodic video follow-ups with their Chinese team after returning home, which costs $100 to $300 per session.

Frequently Asked Questions